Vladimir Nekhendzy

Located in Palo Alto, CA, Jeffrey Tseng is a prominent establishment known for its dedication to providing top-tier healthcare services. This esteemed facility offers a wide range of medical treatments and services, including specialized care in areas such as cancer treatment, cardiovascular services, neurological care, orthopedics, and organ transplantation. With a strong affiliation with Stanford University, Jeffrey Tseng is at the forefront of pioneering research and medical education, ensuring that patients receive cutting-edge treatments and innovative procedures to address their medical needs. At Jeffrey Tseng, patients can expect to receive comprehensive medical expertise from a team of skilled healthcare professionals. The facility operates multiple clinical facilities, outpatient centers, and specialized programs, all aimed at delivering exceptional patient care. Through a collaborative approach that involves physicians, nurses, researchers, and specialists working together, Jeffrey Tseng is committed to supporting patient wellness, advancing clinical knowledge, and continuously refining medical practices to provide the best possible outcomes for those in need of medical care. Generated using this brand's available information

Dr. Michael Iv received his medical degree from the David Geffen School of Medicine at UCLA. He completed his radiology residency training at Santa Clara Valley Medical Center and neuroradiology fellowship at Stanford University. He is board certified in Diagnostic Radiology and also holds a Certificate of Added Qualification in Neuroradiology. His primary research interest focuses on the use of advanced MRI techniques to probe the brain tumor microenvironment and improve our diagnostic capability to effectively monitor a tumor’s response to treatment. Examples include using ferumoxytol-enhanced MRI to image tumor associated macrophages and perfusion MRI to image tumor vascularity and neoangiogenesis.

Nishita Kothary, M.D. is a Professor of Radiology in the section of Interventional Radiology at Stanford University Medical Center. Dr. Kothary’s clinical practice primarily focuses on percutaneous and endovascular therapies for primary and metastatic liver cancer. Her research interests lie in radiogenomics and in the use of advanced imaging in the diagnosis and treatment of hepatocellular carcinoma (HCC). Dr. Kothary is an active member of the Zeego Lab and Integrative Biomedical Imaging Informatics at Stanford. She is the faculty lead for the Out-of-OR Value-based Committee and the co-chair for the overall SHC Value-based Committee.